← Leaderboards
Ludvig Magne Sollid
Stanford University
$585,091
Attributed
$1,755,274
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $364K · FY2021–25$500K$375K$250K$125K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,755,274 · 1
By mechanism
R01$1,755,274 · 1
Top collaborators
- Bana Jabri5 shared
- Chaitan Khosla5 shared
Most similar at Stanford University
Same institution · by research overlap
- John R Huguenard$33,937,491
- Chaitan Khosla$26,183,068
- David Allan Prince$15,709,411
- Rajat Rohatgi$14,464,084
- Joel D Killen$14,646,988
Others in their field
Other Emerging Leaders on “Absorption”
- Aina E. Cohen · Stanford University$10,909,501
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Deborah Bunin · Sri International$10,209,148
- Jay Evans · University Of Montana$9,566,206
- Christian Arthur Heidbreder · Indivior, Inc.$8,445,278
- Richard Joseph Johnson · Colorado Research Partners, Llc$6,102,731
Research focus
AbsorptionAdductActive SitesAntigensAutoantibodiesB-Cell Antigen ReceptorBindingAffinityB-LymphocytesCd4 Positive T LymphocytesCeliac DiseaseCellsClinical TrialsCollaborationsComplexCytokineBiochemicalDesignDietaryEfficacious TreatmentEngineeringEnterocytesEnvironmentEnvironmental Risk Factor
Grant awards (5)
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease$351,340
R01 · FY2025 · DK
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease$337,286
R01 · FY2024 · DK
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease$351,340
R01 · FY2023 · DK
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease$351,340
R01 · FY2022 · DK
Localizing Pathogenically Relevant Transglutaminase 2 in Celiac Disease$363,968
R01 · FY2021 · DK